Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Designed as a triple agonist compound, Retatrutide has been studied for its activity across glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathways
Consistency protects patients during routine medication preparation steps
Wegovy (semaglutide) is a GLP-1 receptor agonist used to help obese adults lose weight
Anazco D, Fansa S, Hurtado MD, et al
How to Speak to a Doctor About Retatrutide Speak to your GP or an obesity medicine specialist about currently licensed alternatives and ask about referral to a clinical trial, as this is the only legitimate UK access route for retatrutide
US$ 24.39
US$ 23.77
US$ 27.66
